Participant Database for Autism Research Studies
The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Massachusetts General Hospital.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Massachusetts General Hospital
Information provided by (Responsible Party):
Martha Herbert, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00549731
First received: October 15, 2007
Last updated: May 31, 2013
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.
| Condition |
|---|
|
Autism Spectrum Disorder Developmental Language Disorders |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Participant Database for Persons Interested in Autism Research Studies: Recruiting, Pre-Screening and Diagnostic Assessment |
Resource links provided by NLM:
Further study details as provided by Massachusetts General Hospital:
| Estimated Enrollment: | 5000 |
| Study Start Date: | June 2005 |
| Estimated Study Completion Date: | January 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities
Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group
Aim 3: to maintain subject information in a database, from which we can recruit for our studies
Eligibility| Ages Eligible for Study: | up to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Adult/Pediatric
Criteria
Inclusion Criteria:
- Enrollment will be open to typically-developing, healthy children and adults (ages 0-45), children and adults with autism spectrum disorder (ages 0-45), siblings of children and adults with autism spectrum disorder (ages 0-45), and children and adults with developmental language delays (ages 0-45).
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00549731
Please refer to this study by its ClinicalTrials.gov identifier: NCT00549731
Contacts
| Contact: Manuel Zetino, Rsch Coord | 617-766-9766 | TRANSCEND@partners.org |
Locations
| United States, Massachusetts | |
| Martinos Center of Biomedical Imaging | Recruiting |
| Charlestown, Massachusetts, United States, 02129 | |
Sponsors and Collaborators
Massachusetts General Hospital
Investigators
| Principal Investigator: | Martha Herbert, MD, Ph.D | Massachusetts General Hospital | |
| Principal Investigator: | Tal Kenet, Ph.D | Massachusetts General Hospital | |
| Principal Investigator: | Katherine Martien, MD | Massachusetts General Hospital/LADDERS |
More Information
No publications provided
| Responsible Party: | Martha Herbert, M.D., PhD, Massachusetts General Hospital |
| ClinicalTrials.gov Identifier: | NCT00549731 History of Changes |
| Other Study ID Numbers: | 2007-P-000062 |
| Study First Received: | October 15, 2007 |
| Last Updated: | May 31, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Massachusetts General Hospital:
|
autism autistic language |
development developmental assessment |
Additional relevant MeSH terms:
|
Language Development Disorders Language Disorders Communication Disorders Nervous System Diseases |
Neurobehavioral Manifestations Neurologic Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on March 03, 2015